DARPA attempting to remove “hallucinatory” “side effects” from psychedelics
…investigating… drug treatments targeting post-traumatic stress disorder and depression that can be administered without the “unpredictable consequences” of current psychedelic medicines.
Underlying the entire Focused Pharma project is a suggestion that the supposed “deleterious neurological effects” of psychedelic agents such as psilocybin and MDMA, are fundamentally unrelated to the efficacy of the drugs. A great deal of research into these substances is suggesting the acute phenomenological experience, often lasting between four and eight hours, is vital to the lasting beneficial effect.
Original Article (New Atlas):
DARPA attempting to remove hallucinatory “side effects” from psychedelic medicines
Artwork Fair Use: M0010591